Selected article for: "antiviral drug and dependent RNA polymerase"
Author: Yin, Wanchao; Mao, Chunyou; Luan, Xiaodong; Shen, Dan-Dan; Shen, Qingya; Su, Haixia; Wang, Xiaoxi; Zhou, Fulai; Zhao, Wenfeng; Gao, Minqi; Chang, Shenghai; Xie, Yuan-Chao; Tian, Guanghui; Jiang, He-Wei; Tao, Sheng-Ce; Shen, Jingshan; Jiang, Yi; Jiang, Hualiang; Xu, Yechun; Zhang, Shuyang; Zhang, Yan; Eric Xu, H.
Title: Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir
  • Cord-id: 7v7pzclb
  • Document date: 2020_4_9
    • ID: 7v7pzclb
    Snippet: The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Ã…. The complex structure reveals that the partial double-stranded RNA template is insert
    Document: The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Ã…. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection.

    Search related documents:
    Co phrase search for related documents
    • active form and additional energy: 1
    • active form and additional nucleotide: 1
    • active form and adenosine triphosphate: 1, 2, 3, 4, 5
    • active rtp remdesivir triphosphate form addition and adenosine triphosphate: 1
    • active rtp remdesivir triphosphate form and adenosine triphosphate: 1
    • active site and additional energy: 1
    • active site and additional nucleotide: 1, 2
    • active site and adenosine analog: 1, 2, 3
    • active site and adenosine triphosphate: 1, 2, 3, 4
    • active site conformation and additional energy: 1
    • active site conformation switch and additional energy: 1
    • active triphosphate form and additional nucleotide: 1
    • active triphosphate form and adenosine triphosphate: 1, 2, 3, 4, 5